Christophe Cellier

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

The American College of Gastroenterology (ACG) is an organization that provides education to gastrointestinal professionals and the public about digestive disorders. The non-profit company is based in Bethesda, MD. The company's mission is to improve the care of patients with gastrointestinal disorders through scientific investigation, education, prevention, and treatment.

Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge.

The Association of Clinical Research Professionals is a non-profit organization that provides over 50 online and in-person training programs for individual sale and institutional licensing. The non-profit company is based in Alexandria, VA and was founded by Lynn E. Regina. The company's courses cover good clinical practice (GCP) and specialized topics, including the anatomy of a protocol, hypothesis development, study design, subject safety, and data integrity risk considerations. The company also offers clinical trial insights research, a solution that combines market research capabilities with unprecedented access. With over 13,000 members, the organization represents, supports, and advocates for clinical research professionals.

American Gastroenterological Association engages in the science and practice of gastroenterology. The private company is based in Bethesda, MD.

Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA.

Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Sanofi-aventis Canada Inc. is the Canadian affiliate of the sanofi-aventis Group, one of the world's leading pharmaceutical companies. They are headquartered in Laval, Quebec, and employ 900 people across the country. Their Laval site is also home to a world-class manufacturing facility that produces medications for use by patients in Canada, the United States and other countries. As a leading healthcare partner they provide, and are developing, innovative medicines for treatments in several therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic disorders, the central nervous system, and internal medicine. They also play a role by investing in activities that improve health and quality of life in their communities. The sanofi-aventis Group is also represented in Canada by Sanofi Pasteur Limited. Located in Toronto, the company is Canada's largest producer of vaccines and employs 1,200 people.

STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain.

Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom.

SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation.

Part of Ipsen SA, Ipsen Bioscience, Inc. is a company that develops and wholesales drugs. The company is based in Cambridge, MA.

Part of Ipsen SA, Ipsen (Beijing) Pharmaceutical Science & Technology Dev develops pharmaceutical sciences and technologies. The company is based in Beijing, China.

Calypso Biotech BV operates as immunotherapy biotech company. It develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Amsterdam, the Netherlands.

Object Pharma, Inc developing botulinum neurotoxins for unmet needs in aesthetic and therapeutic markets. The company is headquartered in New Port Beach, California.

Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland.

Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland.

ImmunoRx Pharma, Inc. manufactures pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Juan Felipe Velasquez.